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C ockaynesyndrome(CS) isa rareautosomal recessivedis-easedescribedbyCockayne1 in 1936 that belongs to thefamily of nucleotide excision repair disorders to-
gether with xeroderma pigmentosum (XP) (xeroderma pig-
mentosum, complementation groupA [XPA;OMIM278700],xe-
rodermapigmentosum, complementation groupB [XPB; OMIM
610651], xeroderma pigmentosum, complementation group C
[XPC; OMIM 278720], xeroderma pigmentosum, complemen-
tation group D [XPD; OMIM 278730], xeroderma pigmento-
sum, complementation group E [XPE; OMIM 278740], xero-
derma pigmentosum, complementation group F [XPF; OMIM
278760], xeroderma pigmentosum, complementation group G
[XPG; OMIM 278780], and xeroderma pigmentosum, variant
type [XPV;OMIM278750])andtrichothiodystrophy (trichothio-
dystrophy photosensitive [TTDP; OMIM 601675]). The inci-
denceofCS is estimated at 1 per 360 000births inWesternEu-
rope. The disease is defined by progressive postnatal growth
failure, microcephaly, mental retardation, retinal degenera-
tion, sensorineural deafness, and photosensitivity.2 Patients
share a characteristic facial appearance, with enophthalmia.
A defective recovery of RNA synthesis in fibroblasts after UV
lightexposure is requiredtoconfirmthediagnosis.3AllCScases
reported so far were due to mutations of the Cockayne syn-
dromeA (CSA; OMIM216400) gene located on chromosome 5
ormutationsof theCockaynesyndromeB (CSB;OMIM133540)
gene on chromosome 10q and were identified in 19924 and
1995,5 respectively.
The cerebro-oculo-facial-skeletal (COFS) syndrome (cere-
bro-oculo-facial-skeletal 1 [COFS1; OMIM 214150]) is an auto-
somal recessive disorder that was first reported6 within the
Manitoba aboriginal population in 1971. Microcephaly, cata-
racts,microphthalmia, facial dysmorphism, andarthrogrypo-
sis are the clinical hallmarks of COFS syndrome. Since publi-
cationof the first cases, clinical reportshaveunderlinedclinical
similarities between COFS syndrome and CS, and mutations
in the CSB gene were recently reported in this syndrome7,8;
COFS syndrome and CS are now considered to be related al-
lelic disorders.8
Cutaneous manifestations constitute one of the major
symptoms leading to clinical suspicion of nucleotide exci-
sion repair disorders. In CS, parents usually report photo-
sensitivity during early childhood but, unlike patients with
xeroderma pigmentosum, those with CS do not develop sun-
induced skin cancers. Therefore, in their comprehensive re-
viewof140patientswithCS,NanceandBerry2highlightedpho-
tosensitivity as a cardinal symptom and noticed dry and thin
IMPORTANCE Cockayne syndrome (CS) and cerebro-oculo-facial-skeletal (COFS) syndrome
are autosomal recessive diseases that belong to the family of nucleotide excision repair
disorders. Our aimwas to describe the cutaneous phenotype of patients with these rare
diseases.
OBSERVATIONS A systematic dermatologic examination of 16 patients included in a European
study of CS was performed. The patients were aged 1 to 28 years. Six patients (38%) had
mutations in the Cockayne syndrome A (CSA) gene, and the remaining had Cockayne
syndrome B (CSB) genemutations. Fourteen patients were classified clinically as having CS
and 2 as having COFS syndrome. Photosensitivity was present in 75% of the patients and was
characterized by sunburn after brief sun exposure. Six patients developed symptoms after
short sun exposure through a windshield. Six patients had pigmentedmacules on
sun-exposed skin, but none developed a skin neoplasm. Twelve patients (75%) displayed
cyanotic acral edema of the extremities. Eight patients had nail dystrophies and 7 had hair
anomalies.
CONCLUSIONS AND RELEVANCE The dermatologic findings of 16 cases of CS and COFS
syndrome highlight the high prevalence of photosensitivity and hair and nail disorders.
Cyanotic acral edemawas present in 75% of our patients, a finding not previously reported
in CS.
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skin, dry hair, and anhidrosis as other dermatologic findings.
In COFS syndrome, photosensitivity is an inconstant feature
that was rarely reported.8
To our knowledge, this is the first prospective study fo-
cusing on dermatologic symptoms in those 2 rare disorders.
A systematicdermatologic examinationof 16patientswithge-
netically and biochemically ascertained CS and COFS syn-
drome was performed to update dermatologic knowledge of
these rare diseases and to inform their differential diagnoses.
Report of Cases
Patient Population
Between September 1, 2006, andMay 31, 2009, 16 patients (10
males and6 females)wereexaminedby2dermatologists (E.F.,
D.L.).PatientscamefromdifferentEuropeancountriesandpar-
ticipated in aprospective studyonCS. Thepatientswere aged
1 to 28 years (mean, 8.8 years). Four patients were brothers,
but there were no twins among them. All patients had been
characterizedgenetically before inclusion: 6hadmutations in
the CSA gene, and CSBmutations were found in 10. All but 2
patients had a diagnosis of CS andwere classified as CS1 (clas-
sical ormoderate), CS2 (severe or early onset), or CS3 (mild or
late onset) according to criteria defined by Nance and Berry2;
2 patients had a diagnosis of COFS syndrome. Demographic,
clinical, and genetic data are reported in the Supplement
(eTable). All but 2 patients (patients 5 and 7) were previously
reported on in a large molecular study.9
The studywas approved by the Comité de Protection des
Personnes, the French equivalent of an ethics committee. In-
formed written consent was provided by the patients’ par-
ents or legal guardians.
Dermatologic Examination
Twodermatologists (E.F., D.L.) performeda complete skin ex-
amination.Apredefinedquestionnaireandchecklistwerecom-
pleted for eachpatient. The following itemswere reported for
eachpatient: age at onset of the dermatologic symptoms; his-
tory of photosensitivity; existence of pigmented macules or
nevi, as well as hair and nail dystrophies; and signs of cuta-
neous aging. Photosensitivity was defined by an erythema-
tous eruption followingminor solar exposure. Sunburnswere
classified as mild (slight erythema), moderate (marked ery-
thema), or severe (erythemawithpain for several days and/or
bullae). Occurrence of sunburnwhile behind awindshield re-
flectsasignificantphotosensitivityandwasalso recorded.Sun-
burn scars andsolar lentigineswere recorded.Theparents and
caregivers of the patients were interviewed on their provi-
sion of solar protection, with type of photoprotection (eg,
clothes and sunscreen) specified.
Pigmentedmacules andneviwere counted and classified
as small (<3 mm) or large (≥3 mm) lesions, and distribution
according to sun-exposed areas (face, neck, neckline, and ex-
posedparts of the limbs) andnonexposedareaswas recorded.
Alopecia, dermo-epidermal atrophy (“cigarette paper”
skin), thin transparent skin, stellar scars, telangiectasis, Bate-
man purpura, and other signs suggestive of cutaneous aging
were recorded. Hair color; hair dystrophies, such as thin hair,
dryhair, andbrittlehair; andnail disorderswereassessed.Any
other cutaneous finding was also noted, and the face (profile
and front view) and skin lesions were photographed.
Photobiologic Explorations
When possible, a photobiologic exploration was performed.
First, phototype was determined following the Fitzpatrick
criteria.10 Minimal erythema dose was determined after irra-
diation (DermolumUMW; FaMüller). The protocol consisted
of irradiation from 200 to 1000mJ/cm2 with broad-spectrum
light on the left buttock and from 2 to 10 J/cm2 with UV-A on
the right buttock.
Results
Clinical Findings
There were 10male and 6 female patients in the study (mean
age, 8.8 years). Demographic and genetic data, as well as der-
matologic findings, are summarized in the Supplement
(eTable).
Photosensitivity
For 12patients, parents reportedphotosensitivity,whichwere
mostly acute symptoms. Sunburns were classified as mild in
2,moderate in7,andseverewithbullae in2patients.Thesymp-
toms appeared before a mean age of 8.4 months (median, 1
month). Six patients developed a photosensitive eruption af-
ter short exposure throughawindshield. Fourpatientsdidnot
have a history of photosensitivity; their parents had used in-
tensivephotoprotectionwithclothesandsunscreensince their
birth.
Sevenpatientsdevelopedskin lesionsonsun-exposedskin:
more than5pigmentedmacules in 7patients and stellate scars
in 1 patient.Wenoticed pigmentedmacules and stellate scars
in 1 patient. These lesions were more prevalent in older pa-
tients (Figure, A). Three patients had more than 20 pig-
mented macules, and 3 patients had more than 5 pigmented
macules on non–sun-exposed skin. The number of pig-
mented lesions is summarized inTable 1 and the Supplement
(eTable).
At the time of the present study, none of the patients had
developed a skin neoplasm. Parents used photoprotection in
16 patients: sunscreen alonewasused in 3 children and cloth-
ing with sunscreen in the remaining 13.
Other Dermatologic Findings
Twelvepatients displayed anacral cyanotic livedo andedema
of the extremities (Figure, B). Most lesions were on the feet.
Investigations did not reveal any general cause that could ex-
plain edema, and albumin level and renal function were nor-
mal. Six patients had skin atrophywith abnormal visibility of
veins. This atrophy predominated in the temporal areas and
on the dorsal part of the hands. Eight patients had nail dys-
trophies. For 5 children, the dystrophy consisted of an exag-
gerated curvature of the nail plate; for 2, accelerated growth
of the nail; and for 2, distal onycholysis with hyperkeratosis.
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The parents of 7 patients reported hair anomalies that were
characterized by exaggerated hair loss in 5 children that was
not related to fever or infection.We did not observe alopecia.
All but 3 patients, including those with COFS syndrome, dis-
played loss of subcutaneous orbital fat leading to enophthal-
mia. Other rare dermatologic findings are summarized in
Table 2.
Photobiologic Exploration
Photobiologic explorationwasperformed in 10children.Three
had normal minimal erythema dose, whereas 4 had lowered
minimal erythema dose (≤400mJ/cm2). After 24 hours, an it-
erative phototest was erythematous in 4 patients and be-
camebullous in 2 children after 6 days. All children recovered
after 13 days.
Hair Findings
Atypical alternating dark and light bandswere observed in 14
patients on microscopic examination with polarized light
(Figure, C). This pseudo “tiger-tail” appearance was not con-
stant in each hair and was not localized in the distal part but
rather was distributed randomly within the hair shaft. There
was no trichoschisis. Amino acid analysis was not per-
formed.
Discussion
In this study of 16 patients with genetically characterized CS
and COFS syndrome, the high prevalence of photosensitivity
was confirmed as an early sign of the disease. Acral cyanosis
Figure. Dermatologic and Hair Findings of 3 PatientsWith Cockayne Syndrome
A B
C
A, A 28-year-old womanwith
pigmentedmacules on sun-exposed
area (left arm). B, Cyanotic edema of
the right leg in a 3-year-old child.
C, Pseudo “tiger-tail” appearance of 1
hair shaft (polarizedmicroscopic
examination; original magnification
×400).
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with slight peripheral edema,which toour knowledgehasnot
been previously reported, was present in 75% of the patients
withCS.Toourknowledge, this report is the first extensivede-
scription of skin findings in a cohort of patients with geneti-
cally ascertained CS and COFS syndrome.
Photosensitivitywas themajordermatologic symptomand
occurred in12ofourpatients,but the4remainingchildrenwere
never sun exposed. In 1992, Nance and Berry2 proposed cri-
teria for clinical diagnosis ofCS, andphotosensitivitywas clas-
sified as a minor criterion. In a review of the literature, they
found72%ofpatientswithahistoryof sundamage.Later,pho-
tosensitivity was reported11 in 24 (96%) patients with CS con-
firmed by defective post-UV RNA synthesis, and photosensi-
tivitywas then cited as themost frequent symptom inCS. For
6 of the patients (50%), sunburn appeared when the patient
wasbehindawindshield,which isan indicatorofhighskinsen-
sitivity to UV light.
Cockayne syndrome usually is not associated with sun-
inducedpigmentation, and this absence is consideredas a car-
dinal sign fordifferentiationwithxerodermapigmentosum.2,12
Among our patients, 7 had pigmented lesions on sun-
exposed areas, but only 3 of these individuals hadmore than
20 lesions. An explanation for this paucity of pigmented le-
sions could be that, because children with CS develop severe
sunburns even during a short time of exposure, their parents
provide protection beginning at a very young age. This hy-
pothesis is supported by the intensive photoprotection re-
ported by the parents in this population.
Acral edemawas the secondmost frequent dermatologic
symptom, occurring in 75% of our patients. To our knowl-
edge, it has never been reported in CS. Ozdirim et al13 de-
scribed large feet and hands in 14 of 25 patients (56%) but did
not mention edema. In the present study, edema was cya-
notic with increased visibility of veins because of skin atro-
phy. It predominated in the feet andwasmore apparent with
low temperatures. A neurologic cause was suspected be-
cause vascular complications of paralyzing neurologic disor-
ders arewell known topractitioners, although theyhavebeen
rarely reported.14Thesevascular complications consist of cold
and edematous feetwith acrocyanosis, aswe observed in our
patients. However, we also observed hand edema in one pa-
tient, a situation that is not common in neurologic paralyzing
diseases.
Cockayne syndrome belongs to the progeroid syn-
dromes.When patients with CS grow older, the fat surround-
ing their eyes isprogressively reduced, leading to sunkeneyes,
and the skin becomes thin. Thin skin predominates on tem-
poral areas,withabnormalvisualizationofveins.Thinskinwas
oneof themajor skin symptoms in a large review, and it is also
observed in trichothiodystrophy.2
In our cohort, exaggerated hair loss was found in 5
patients (31%), a smaller percentage than that reported in
individuals with trichothiodystrophy, for whom sparse hair
occurred in 48% and alopecia was mentioned in 39%.15 Nails
of our patients had abnormal longitudinal curvature (club-
bing) in 5 cases (31%), abnormal growth in 2 cases (12%), and
distal onycholysis with distal hyperkeratosis in 2 cases. To
our knowledge, nail disorders were not reported in patients
with CS or xeroderma pigmentosum. Dysplasia, splitting
(onychoschizia), koilonychias, ridging, thickening (onycho-
gryphosis), yellow discoloration, brittle nails, hypoplasia,
Table 1. Number of Pigmented LesionsMeasuring Less Than 3mm
No. of Lesions No. of Patientsa
Sun-exposed areas
<5 9
5-10 3
11-20 0
>20 3
Sun-unexposed areas
<5 12
5-10 1
11-20 1
>20 0
a Data reported only as yes or no in some categories.
Table 2. Rare Dermatologic Findings in 16 Patients
With Cockayne Syndrome
Symptom No. of Patients
Nails
Hyperlongitudinal curvature of the fingernails 5
Accelerated nail growth 2
Distal onycholysis 2
Ungual hyperkeratosis 2
Hair and body hair
Exaggerated hair loss 5
Accelerated hair growth 1
Hypertrichosis of the lower limbs 1
Mouth and tongue
Geographic tongue 2
Cheilitis 1
Small mouth 1
Pigmented and achromic lesions
Multiple large non–blaschko-linear pigmented macules 1
Cafe-au-lait spot 1
Mongolian spot of the lumbar area 1
Achromic macule localized on the trunk or buttock 2
Angioma and vascular disorders
Acral edema 12
Stellate angioma of the right cheek 1
Tuberous angioma (present at birth) 1
Telangiectasia of the cheek 2
Atrophic skin and scars
Atrophic skin 6
Scars on the dorsal hands and nose 1
Other symptoms
Atopic eczema 1
Xerosis 2
Pilonidal sinus 1
Bradymetacarpia of the fifth fingers 1
Pityriasis versicolor on the trunk 2
Facial acne 2
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and unguis inflexus were noted in large reviews of
trichothiodystrophy and occurred in 63% of the patients,15
but no patients had nail clubbing. Clubbing was thought to
be secondary to nail hypervascularization and cyanosis.16 In
our patients, hypertransverse curvature and acral edema
might be related to these conditions.
Nance and Berry2 noticed dry and sometimes scaly skin
as dermatologic signs of CS. They related these signs to anhi-
drosis secondary to hypoplasia of the eccrine sweat glands.
Xerosis constituted a dermatologic finding in only 2 of our
patients.
In conclusion, inaddition to theknowndermatologic find-
ingsof ahighprevalenceofphotosensitivity aswell ashair and
nail disorders, these 16 cases of CS and COFS syndrome ex-
hibited cyanotic acral edema. To our knowledge, this finding
has not been previously reported in CS.
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